We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Adopts Arthritis Drugs as Treatments for Severe COVID-19 Patients
UK Adopts Arthritis Drugs as Treatments for Severe COVID-19 Patients
The UK’s National Health Service (NHS) will begin treating adult COVID-19 patients in intensive care with Roche’s and Sanofi’s arthritis medications following positive trial results that showed the drugs were highly effective when given early enough.